Recent research indicates that there are age-associated gender differences seen in the disease burden of chronic obstructive pulmonary disorder (COPD), with younger women more severely affected.
Recent research indicates that there are age-associated gender differences seen in the disease burden of chronic obstructive pulmonary disorder (COPD), with younger women more severely affected.
A study involving 4484 individuals with COPD demonstrated that younger women were more likely than younger men to exhibit severe dyspnea, more severe airflow limitation, were at greater risk for exacerbations, and had more severe disease classification according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines.
These gender associations were less pronounced among adults 65 years or older, particularly in regards to dyspnea, airflow limitations, and GOLD classification. However, older women with COPD were still more likely to experience dyspnea and present with more severe COPD than older men.
The results suggest that women are more significantly burdened by the symptoms of COPD than men and that younger women may be particularly susceptible. COPD, the third-leading cause of death in the United States, has traditionally been viewed as a male disease. But prevalence and mortality are on the rise in women. This has been attributed to increasing rates of smoking among women, although it is also possible that women are more susceptible to the harmful effects of cigarette smoke and other known COPD risk factors.
Participants were drawn from the long-running Genetic Epidemiology of COPD study (COPDGene), which seeks to find new information about genetic factors in COPD. The COPDGene study, involving 21 academic clinical centers, is an observational cohort of current and former smokers aged between 45 and 80 years at enrollment, who reported at least 10 pack-years of cigarette smoking and self-identified as either non-Hispanic white or African-American.
The objective of the present study was to explore gender-by-age interactions and disease severity as defined by GOLD groupings and the 3 key contributing elements of the GOLD classification system (symptoms, exacerbation risk, and airflow limitation severity) using data from a large well-phenotyped COPD cohort. A detailed approach was adopted to consider age by 5-year increments and to identify clinically relevant age cutoffs from which to examine these differences.
There were 2522 individuals with COPD in the under-65 year age group and 1962 in the 65 and older group. The proportion of women in each age group was similar (42.8% vs 45%); the majority of participants across both sexes were white and had higher education.
The study found:
The researchers said more studies are needed to understand the pathogenesis of increased severity of COPD in women and to develop gender-targeted clinical assessment and management approaches to improve outcomes for women and men with COPD at all ages.
Reference
DeMeo DL, Ramagopalan S, Kavati A, Vegesna A, Han MK, Yadao A, et al. Women manifest more severe COPD symptoms across the life course. [published online October 1, 2018]. Int J Chron Obstruct Pulmon Dis. doi: 10.2147/COPD.S160270
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More